{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
cyclophosphamide
to a specific field?
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2014)
Source URL:
First approved in 2014
Source:
MELAMIN Skin Bleaching and Correcting Hydroquinone by ZO Skin Health, Inc.
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Status:
US Approved Rx
(2013)
First approved in 1958
Class:
MIXTURE
Status:
Investigational
Source:
NCT00523159: Phase 2 Interventional Completed Renal Cell Carcinoma
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00523159: Phase 2 Interventional Completed Renal Cell Carcinoma
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00523159: Phase 2 Interventional Completed Renal Cell Carcinoma
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00523159: Phase 2 Interventional Completed Renal Cell Carcinoma
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00523159: Phase 2 Interventional Completed Renal Cell Carcinoma
(2007)
Source URL:
Class:
PROTEIN